Jessica M. Khouri <Jessica.Khouri@cdph.ca.gov> [edited]Re: Infant botulism - USA: (CA) possible dust exposures 20170420.4982800 --------------------------------------------------------------------------------Please see the list below for additional references the ProMED moderator may wish to include related to the appended post. Of note, the name of the human antitoxin licensed by the US FDA for the treatment of infant botulism due to toxin types A and B is BIG-IV, Botulism Immune Globulin Intravenous (Human), proprietary name BabyBIG [R]. The commentary below states the name of the product as ""BIG"".1. Centers for Disease Control and Prevention. National Botulism Surveillance <https://www.cdc.gov/botulism/surveillance.html>.2. Arnon SS: Creation and development of the public service orphan drug Human Botulism Immune Globulin. Pediatrics. 2007;119 (4):785-9; abstract available at: <https://www.ncbi.nlm.nih.gov/pubmed/17403850>.3. Arnon SS, Schechter R, Maslanka SE, Jewell NP and Hatheway CL: Human Botulism Immune Globulin for the treatment of infant botulism. N Engl J Med. 2006;354(5):462-71; available at <http://www.nejm.org/doi/full/10.1056/NEJMoa051926>.4 Dabritz HA, Hill KK, Barash JR, et al: Molecular epidemiology of infant botulism in California and elsewhere, 1976-2010. J Infect Dis. 2014;210(11):1711-22; available at: <https://academic.oup.com/jid/article-lookup/doi/10.1093/infdis/jiu331>.More information and resources regarding infant botulism may be found at the Infant Botulism Treatment and Prevention Program's website, <http://www.infantbotulism.org>.--Jessica M. Khouri, M.D.Senior Medical OfficerInfant Botulism Treatment and Prevention ProgramInfectious Diseases Laboratory BranchDivision of Communicable Disease ControlCenter for Infectious DiseasesCalifornia Department of Public Health<Jessica.Khouri@cdph.ca.gov>[ProMED thanks Dr. Khouri for her contribution. - Mod.LLA HealthMap/ProMED-mail map can be accessed at: <http://healthmap.org/promed/p/204>.]
